Updated:
Nabriva Therapeutics plc
Nabriva Therapeutics plc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001641640, and its reported...
Overview
Nabriva Therapeutics plc is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001641640, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-04-17, it reported annual revenue of USD 36,935,000; net income of USD -57,185,000; total assets of USD 31,765,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Nabriva Therapeutics plc
- Former names in filing history
- Nabriva Therapeutics AG (2015-05-14 to 2017-07-10)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Dublin, Ireland
- Incorporated in
- Ireland
- Fiscal year end
- December 31
- SEC CIK
- 0001641640
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2022USD | $36.9M | -$57.2M | $31.8M | $12.4M | -$36.7M | |
| FY2021USD | $28.9M | -$49.5M | $80.9M | $47.7M | -$59.6M | |
| FY2020USD | $5.0M | -$69.5M | $58.4M | $41.4M | -$71.3M | |
| FY2019USD | $9.5M | -$82.8M | $94.1M | $86.0M | -$71.9M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-Q | 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| 10-K | 10-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Nabriva Therapeutics plc in Altss
Track this company’s investors, transactions and relationships in Altss.